+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Exelixis Inc - logo
Fallopian Tube Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Fallopian Tube Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 871 Pages
  • Global
From
Antibody Drug Conjugates (ADCs) - Linker and Conjugation Technologies Market, 2019-2030 - Product Thumbnail Image

Antibody Drug Conjugates (ADCs) - Linker and Conjugation Technologies Market, 2019-2030

  • Report
  • November 2019
  • 310 Pages
  • Global
From
Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market 2024-2028 - Product Thumbnail Image

Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market 2024-2028

  • Report
  • December 2023
  • 163 Pages
  • Global
From
Hereditary Angioedema Therapeutics Global Market Report 2024 - Product Thumbnail Image

Hereditary Angioedema Therapeutics Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1588 Pages
  • Global
From
Monoclonal antibodies - Competitive landscape, 2023 - Product Thumbnail Image

Monoclonal antibodies - Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 3237 Pages
  • Global
From
Cervical Cancer Therapeutics Market - Epidemiology & Pipeline Analysis 2022-2027 - Product Thumbnail Image

Cervical Cancer Therapeutics Market - Epidemiology & Pipeline Analysis 2022-2027

  • Report
  • June 2022
  • 191 Pages
  • Global
From
Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 143 Pages
  • Global
From
Neuroblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Neuroblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 308 Pages
  • Global
From
Pontine Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Pontine Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 138 Pages
  • Global
From
Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 2271 Pages
  • Global
From
Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 574 Pages
  • Global
From
mTOR Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

mTOR Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • November 2023
  • 181 Pages
  • Global
From
Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 1663 Pages
  • Global
From
Pheochromocytoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Pheochromocytoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 161 Pages
  • Global
From
Hepatocellular Carcinoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Hepatocellular Carcinoma - Pipeline Review, H1 2018

  • Drug Pipelines
  • May 2018
  • 1275 Pages
  • Global
From
Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 1814 Pages
  • Global
From
Gastric Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Gastric Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 550 Pages
  • Global
From
Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1182 Pages
  • Global
From
Loading Indicator